MD Anderson Cancer Center

Nabsys Takes Blood Cancer Genome Mapping Data to AMP 2026

Image
Nabsys Takes Blood Cancer Genome Mapping Data to AMP 2026

PROVIDENCE – November 05, 2026 -- Electronic Genome Mapping (EGM) detected every abnormality identified by standard cytogenetic testing in an initial study, according to researchers from Augusta University and The University of Texas MD Anderson Cancer Center. They will present the findings at the Association for Molecular Pathology (AMP) 2026 Annual Meeting, November 10-14 in Seattle, Nabsys 2.0, LLC said.

Augusta and MD Anderson pathologists present EGM data on November 13

Ravindra Kolhe, M.D., Ph.D., Professor and Chair of Pathology at Augusta University, and Rashmi Kanagal-Shamanna, M.D., Professor of Hematopathology and Molecular Diagnostics at MD Anderson, will present at the Innovation Spotlight Session (stage 1). The slot runs 9:30-10:00 a.m. PT on Friday, November 13. The talk is titled "Electronic Genome Mapping for Structural Variant Detection: Implications for Advancing Clinical Research in Heme Malignancies."

SITC Sets Nov. 4 Briefing on Eight Cancer Immunotherapy Abstracts

Image
SITC Sets Nov. 4 Briefing on Eight Cancer Immunotherapy Abstracts

MILWAUKEE – October 29, 2026 -- The Society for Immunotherapy of Cancer (SITC) received almost 1,200 abstract submissions for 2026 and will showcase eight selected studies at a virtual press briefing on Wednesday, Nov. 4, from 12 to 1:30 p.m. MT.

SITC publishes accepted late-breaking abstracts ahead of its 41st Annual Meeting

The society has released titles and authors for the accepted Late-breaking Abstracts, which contain new data from interventional clinical trials in humans. They will be presented at the 41st Annual Meeting & Pre-Conference Programs, held Nov. 4-8, 2026, in Phoenix, AZ, and virtually.

Briefing lineup spans cell therapies, oncolytic viruses and a PD-1/VEGF bispecific

Eight presentations are scheduled, in this order:

China Inbound Medical Tourism Jumps 73.6% as Jiahui Cites WTO Forum

Geneva – September 20, 2026 -- China's leading hospitals serving international patients recorded 1.28 million international patient visits in 2025, up 73.6% from three years earlier, Dr. John K. Hsiang, Chairman of Jiahui Health's Executive Committee, said at the WTO Public Forum 2026.

Inbound patient volumes surge past 1.28 million visits in 2025

Of the 1.28 million total visits, 413,000 were made by patients who travelled to China specifically for medical care, according to data cited by Dr. Hsiang. At Jiahui Health, overseas patient inquiries nearly doubled year on year in the first half of 2026. Dr. Hsiang was the sole Chinese healthcare representative invited to the forum's "Health Without Borders" session on medical tourism in services trade.